Principia Biopharma Inc is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer
Principia Biopharma Inc is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer. It utilizes its proprietary Tailored Covalency platform to develop drug candidates such as rilzabrutinib and PRN2246.